Skip to main content
Accessibility  |  Contact  |  Privacy  |  Terms of Service

66% of Prostate Cancer Patients do not need Treatment

  • Published: 2009-09-23 : Author: University of Liverpool
  • Synopsis: Studies show men with non-aggressive prostate cancer can live with the disease untreated for many years.

Main Document

Globally, prostate cancer is the fifth most common malignancy and accounts for 13% of male deaths in the UK. Studies have shown that men with non-aggressive prostate cancer can live with the disease untreated for many years, but aggressive cancer requires immediate treatment.

In the largest study of its kind, the international team of pathologists studied an initial 4,000 prostate cancer patients over a period of 15 years to further understanding into the natural progression of the disease and how it should be managed. The research, published in the British Journal of Cancer , could be used to develop a blood test to distinguish between aggressive and non-aggressive forms of prostate cancer.

Globally, prostate cancer is the fifth most common malignancy and accounts for 13% of male deaths in the UK. Studies have shown that men with non-aggressive prostate cancer can live with the disease untreated for many years, but aggressive cancer requires immediate treatment.

Pathologists found that the presence of a protein, called Hsp-27, in cancer cells was an indicator that the disease will progress and require treatment. The study showed, however, that in more than 60% of cases the protein was not expressed and the cancer could be managed by careful monitoring, rather than with active invention methods, such as drug treatment or surgery.

The protein normally has a positive function in the body, helping healthy cells survive when they are placed under 'stressful' conditions, such as disease or injury. If the protein is expressed in cancer, however, it can prevent the diseased cells from dying, allowing the cancer to progress. The team, supported by Cancer Research UK (CRUK) and in collaboration with scientists in London and New York, found that the protein can be used to predict how the disease will behave and could help doctors advise patients on how the disease could affect their daily lives.

Professor Chris Foster, Head of the University's Division of Pathology, explains: "Cancer of any kind is a very distressing disease and has the ability to impact on every aspect of a person's life. Chemotherapy and surgery can also have a significant effect on health and wellbeing and that is why it is important that we first understand the biological nature of the disease and how it will behave in each individual patient, before determining if and when a person needs a particular type of treatment.

"By studying the disease in a large number of men throughout the UK and over a long period of time, we have been able to get a more complete picture of how to manage the disease successfully, whilst limiting the negative impact it can have on a patient's life. The study also demonstrates the role of modern of Pathology, not only in establishing diagnoses but in determining if the subsequent management of individual patients is biologically appropriate for their particular condition.

"The protein - or biomarker - we have identified provides us with a signal that the disease will continue to progress. We know that at the point this marker is expressed, medics need to administer treatment to kill the cancer cells. We have shown that in the majority of cases, however, this marker is not expressed and therefore patients do not necessarily need to go through treatment to lead a normal life."

1. Patients looking for more information about the new test should discuss the procedure with a Consultant Urologist. Currently, the test can be performed after the patient has undergone a biopsy. Scientists are now working to allow the test to be conducted by blood test.

2. Pathology research at Liverpool is internationally renowned. The division provides services in diagnostic pathology to the Royal Liverpool and Broadgreen University Hospitals Trust as well as offering services in specialized fields of pathology to several other hospitals in the North of England.

3. Cancer Research UK is the world's leading independent organization dedicated to cancer research. The organization supports research into all aspects of cancer through the work of more than 4,500 scientists, doctors and nurses.

4. The BJC is owned by Cancer Research UK. Its mission is to encourage communication of the very best cancer research from laboratories and clinics in all countries. Broad coverage, its editorial independence and consistent high standards have made BJC one of the world's premier general cancer journals.

5. The University of Liverpool is a member of the Russell Group of leading research-intensive institutions in the UK. It attracts collaborative and contract research commissions from a wide range of national and international organizations valued at more than £93 million annually.

Similar Topics

1 : Prostate MRI Reveals More Treatable Cancers and Reduces Overdiagnosis : European Association of Urology.
2 : A More Complete Mediterranean Diet May Protect Against Aggressive Prostate Cancer : Elsevier.
3 : Digital Rectal Exam Vs. PSA Test For Prostate Cancer : Dr. David Samadi Prostate Cancer Center.
4 : First Prostate Cancer Patients Treated with HIFU Technology : HIFU Prostate Services, LLC.
5 : Male Prostate Exam: PSA, DRE and PVR Tests : Dr. David Samadi.
From our Prostate Cancer section - Full List (35 Items)

Submit disability news, coming events, as well as assistive technology product news and reviews.

Loan Information for low income singles, families, seniors and disabled. Includes home, vehicle and personal loans.

Famous People with Disabilities - Well known people with disabilities and conditions who contributed to society.

List of awareness ribbon colors and their meaning. Also see our calendar of awareness dates.

Blood Pressure Chart - What should your blood pressure be, and information on blood group types/compatibility.

1 : Smartphone Addiction is More Addiction to Social Interaction
2 : Actress Eileen Grubba Advocates for Inclusion from Hollywood to the Boardroom
3 : Types of Genetic Mutations Associated with Nephrotic Syndrome Identified
4 : Fighting My Cancer as Much as Possible - Why Many Patients Join Phase 1 Clinical Trials
5 : Social Stigma Can Stand in the Way of Food Insecurity Screening


Disclaimer: This site does not employ and is not overseen by medical professionals. Content on Disabled World is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. See our Terms of Service for more information.

Reporting Errors: Disabled World is an independent website, your assistance in reporting outdated or inaccurate information is appreciated. If you find an error please let us know.